Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-01-02 @ 12:36 PM
Study NCT ID:
NCT00092404
Status:
COMPLETED
Last Update Posted:
2017-03-15
First Post:
2004-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-12
Start Date Type:
None
Primary Completion Date:
2005-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-06
Completion Date Type:
ACTUAL
First Submit Date:
2004-09-22
First Submit QC Date:
None
Study First Post Date:
2004-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-14
Last Update Post Date:
2017-03-15
Last Update Post Date Type:
ACTUAL